TLR9 and hepatocellular carcinoma: In mice deleted for TGF β-activated kinase 1 (Tak1Hep) known to develop inflammation and HCC, TLR4 and TLR9-MyD88 were found to be the driving forces of progression to cancer (Song et al. 2018).